These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


69 related items for PubMed ID: 24053150

  • 1. Clinical trial risk in castration-resistant prostate cancer: immunotherapies show promise.
    Tenuta A, Klotz L, Parker JL.
    BJU Int; 2014 May; 113(5b):E82-9. PubMed ID: 24053150
    [Abstract] [Full Text] [Related]

  • 2. [Current status and future direction of the treatment of CRPC (castration resistant prostate cancer)].
    Akaza H.
    Nihon Rinsho; 2014 Dec; 72(12):2108-15. PubMed ID: 25518342
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Current, new and novel therapy for castration-resistant prostate cancer.
    Gaya JM, Ahallal Y, Sanchez-Salas R, Barret E, Rozet F, Galiano M, Macek P, Durand M, Cerruti J, Prapotnich D, Ropert S, Bennamoun M, Cathelineau X.
    Expert Rev Anticancer Ther; 2013 Jul; 13(7):819-27. PubMed ID: 23875660
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. New and emerging agents for the treatment of castration-resistant prostate cancer.
    Higano CS, Crawford ED.
    Urol Oncol; 2011 Jul; 29(6 Suppl):S1-8. PubMed ID: 22074657
    [Abstract] [Full Text] [Related]

  • 8. Novel therapeutics for the management of castration-resistant prostate cancer (CRPC).
    Lee DJ, Cha EK, Dubin JM, Beltran H, Chromecki TF, Fajkovic H, Scherr DS, Tagawa ST, Shariat SF.
    BJU Int; 2012 Apr; 109(7):968-85. PubMed ID: 22035221
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Biomarkers and receptor targeted therapies reduce clinical trial risk in non-small-cell lung cancer.
    Falconi A, Lopes G, Parker JL.
    J Thorac Oncol; 2014 Feb; 9(2):163-9. PubMed ID: 24419412
    [Abstract] [Full Text] [Related]

  • 11. [Evaluation and diagnosis for castration resistant prostate cancer: CRPC].
    Kamoto T.
    Nihon Rinsho; 2014 Dec; 72(12):2103-7. PubMed ID: 25518341
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Using surrogate biomarkers to predict clinical benefit in men with castration-resistant prostate cancer: an update and review of the literature.
    Armstrong AJ, Febbo PG.
    Oncologist; 2009 Aug; 14(8):816-27. PubMed ID: 19684076
    [Abstract] [Full Text] [Related]

  • 14. The utility of prostate-specific antigen in the management of advanced prostate cancer.
    Crawford ED, Bennett CL, Andriole GL, Garnick MB, Petrylak DP.
    BJU Int; 2013 Sep; 112(5):548-60. PubMed ID: 23826876
    [Abstract] [Full Text] [Related]

  • 15. [Gene therapy for castration resistant prostate cancer].
    Nasu Y.
    Nihon Rinsho; 2014 Dec; 72(12):2152-7. PubMed ID: 25518350
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer].
    Mottet N, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V, Schmid HP, van der Kwast T, Wiegel T, Zattoni F, Heidenreich A.
    Actas Urol Esp; 2011 Dec; 35(10):565-79. PubMed ID: 21757258
    [Abstract] [Full Text] [Related]

  • 20. Prostate-specific antigen response to deferred combined androgen blockade therapy using bicalutamide predicts survival after subsequent oestrogen and docetaxel therapies in patients with castration-resistant prostate cancer.
    Kijima T, Fujii Y, Yokoyama M, Ishioka J, Matsuoka Y, Numao N, Saito K, Koga F, Masuda H, Kawakami S, Kihara K.
    BJU Int; 2012 Oct; 110(8):1149-55. PubMed ID: 22369348
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.